Imaging Polyglutamine Deposits in Brain Tissue

Methods in Enzymology

Volumn 412, Issue , 2006, Pages 106-122

  Osmand, Alexander P ^a   Berthelier, Valerie ^a   Wetzel, Ronald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUTAMINE; MONOCLONAL ANTIBODY; POLYGLUTAMINE; TATA BINDING PROTEIN;

BRAIN TISSUE; CLINICAL PROTOCOL; CORRELATION ANALYSIS; CYTOPLASM; DEGENERATIVE DISEASE; EXPERIMENTAL ANIMAL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR IMAGING; NEUROIMAGING; NEUTROPHIL; NONHUMAN; PEPTIDE SYNTHESIS; PERIKARYON; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; TISSUE DISTRIBUTION;

BRAIN; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDES; TRINUCLEOTIDE REPEAT EXPANSION;

ANIMALIA;

EID: 33749623913     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)12008-X     Document Type: Review

References (30)

1. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem. 40 (1992) 1457-1463
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
3. Bates G., Harper P.S., and Jones L. "Huntington's Disease." (2002), Oxford University Press, Oxford, New York
4. Berghorn K.A., Bonnett J.H., and Hoffman G.E. cFos immunoreactivity is enhanced with biotin amplification. J. Histochem. Cytochem. 42 (1994) 1635-1642
5. Berthelier V., Hamilton J.B., Chen S., and Wetzel R. A microtiter plate assay for polyglutamine aggregate extension. Anal. Biochem. 295 (2001) 227-236
6. Chen S., Berthelier V., Hamilton J.B., O'Nuallain B., and Wetzel R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41 (2002) 7391-7399
7. Chen S., and Wetzel R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci. 10 (2001) 887-891
8. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., and Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19 (1998) 148-154
9. Davies S.W., Sathasivam K., Hobbs C., Doherty P., Mangiarini L., Scherzinger E., Wanker E.E., and Bates G.P. Detection of polyglutamine aggregation in mouse models. In: Wetzel R. (Ed). "Methods in Enzymology," Vol. 309 (1999), Academic Press, San Diego, CA 687-701
10. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
11. Esler W.P., Mantyh P.W., and Maggio J.E. Deposition of soluble amyloid-β into amyloid templates: With application to the identification of amyloid fibril extension inhibitors. In: Wetzel R. (Ed). "Methods in Enzymology" Vol. 309 (1999), Academic Press, San Diego 350-374
12. Goti D., Katzen S.M., Mez J., Kurtis N., Kiluk J., Ben-Haiem L., Jenkins N.A., Copeland N.G., Kakizuka A., Sharp A.H., Ross C.A., Mouton P.R., and Colomer V. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J. Neurosci. 24 (2004) 10266-10279
13. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., and Li X.J. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology. J. Neurosci. 19 (1999) 2322-2334
14. Huang C.C., Faber P.W., Persichetti F., Mittal V., Vonsattel J.P., MacDonald M.E., and Gusella J.F. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24 (1998) 217-233
15. Levine M.S., Cepeda C., Hickey M.A., Fleming S.M., and Chesselet M.F. Genetic mouse models of Huntington's and Parkinson's diseases: Illuminating but imperfect. Trends Neurosci. 27 (2004) 691-697
16. Lunkes A., Trottier Y., Fagart J., Schultz P., Zeder-Lutz G., Moras D., and Mandel J.L. Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 (1999) 1013-1019
17. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., and Chesselet M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 465 (2003) 11-26
18. Murphy C.L., Eulitz M., Hrncic R., Sletten K., Westermark P., Williams T., Macy S.D., Wooliver C., Wall J., Weiss D.T., and Solomon A. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am. J. Clin. Pathol. 116 (2001) 135-142
19. O'Nuallain B., Thakur A., Williams A., Bhattacharyya A., Chen S., Thiagarajan G., and Wetzel R. Kinetics and thermodynamics of amyloid assembly using an HPLC-based sedimentation assay 413 (2006) (in press)
20. Paulson H.L., Perez M.K., Trottier Y., Trojanowski J.Q., Subramony S.H., Das S.S., Vig P., Mandel J.L., Fischbeck K.H., and Pittman R.N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19 (1997) 333-344
21. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91 (1994) 5355-5358
22. Rosene D.L., Roy N.J., and Davis B.J. A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifact. J. Histochem. Cytochem. 34 (1986) 1301-1315
23. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., and Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90 (1997) 549-558
24. Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., Hasenbank R., Bates G.P., Lehrach H., and Wanker E.E. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. USA 96 (1999) 4604-4609
25. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., Oh R., Bissada N., Hossain S.M., Yang Y.Z., Li X.J., Simpson E.M., Gutekunst C.A., Leavitt B.R., and Hayden M.R. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12 (2003) 1555-1567
26. Trottier Y., Lutz Y., Stevanin G., Imbert G., Devys D., Cancel G., Saudou F., Weber C., David G., Tora L., Agid Y., Brice A., and Mandel J.-M. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378 (1995) 403-406
27. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., Bader M., Pabst R., Kobbe P., Krotova J., Stiller D., Kask A., Vaarmann A., Rathke-Hartlieb S., Schulz J.B., Grasshoff U., Bauer I., Vieira-Saecker A.M., Paul M., Jones L., Lindenberg K.S., Landwehrmeyer B., Bauer A., Li X.J., and Riess O. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12 (2003) 617-624
28. Wells R.D., Warren S.T., and Sarmiento M. "Genetic Instabilities and Hereditary Neurological Diseases." (1998), Academic Press, San Diego, CA
29. Westermark G.T., Johnson K.H., and Westermark P. Staining methods for identification of amyloid in tissue. In: Wetzel R. (Ed). "Methods in Enzymology," Vol. 309 (1999), Academic Press, San Diego, CA 3-25
30. Wetzel R. Chemical and physical properties of polyglutamine repeat sequences. In: Ashizawa T., and Wells R.D. (Eds). "Genetic Instabilities and Hereditary Neurological Diseases,". 2nd Ed. (2006), Elsevier-Academic Press, Amsterdam